200 related articles for article (PubMed ID: 17634422)
1. Role of growth factor receptor bound protein 7 in hepatocellular carcinoma.
Itoh S; Taketomi A; Tanaka S; Harimoto N; Yamashita Y; Aishima S; Maeda T; Shirabe K; Shimada M; Maehara Y
Mol Cancer Res; 2007 Jul; 5(7):667-73. PubMed ID: 17634422
[TBL] [Abstract][Full Text] [Related]
2. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
3. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
[TBL] [Abstract][Full Text] [Related]
4. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
6. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
7. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
[TBL] [Abstract][Full Text] [Related]
8. Fascin expression in progression and prognosis of hepatocellular carcinoma.
Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
[TBL] [Abstract][Full Text] [Related]
9. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
11. Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
Shengbing Z; Feng LJ; Bin W; Lingyun G; Aimin H
Anat Rec (Hoboken); 2009 Aug; 292(8):1128-34. PubMed ID: 19645016
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
15. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
16. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD
J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
19. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
